deepull unveils 1 hour, direct-from-blood multiplex PCR test for 95% of sepsis-causing pathogens at ESCMID 2024
25 avr. 2024 03h00 HE
|
DeepUll
deepull unveils 1 hour, direct-from-blood multiplex PCR test for 95% of sepsis-causing pathogens at ESCMID 2024 UllCORE is designed to transform life-saving clinical decision making for sepsis...
deepull appoints Kimberle Chapin, MD, as Chief Medical Officer and Wade Stevenson as Chief Marketing and Sales Officer
18 avr. 2024 02h00 HE
|
DeepUll
deepull appoints Kimberle Chapin, MD, as Chief Medical Officer and Wade Stevenson as Chief Marketing and Sales Officer Kimberle Chapin brings significant expertise in microbiology and infectious...
Spain: EUR 20 million EIB loan to DeepUll accelerates early detection and diagnosis of Sepsis
13 déc. 2022 03h30 HE
|
DeepUll
PRESS RELEASE Luxembourg, 13th December 2022 Spain: EUR 20 million EIB loan to DeepUll accelerates early detection and diagnosis of Sepsis The EIB and...
DeepUll raises €13M Series B financing to progress early sepsis recognition platform
20 oct. 2022 01h00 HE
|
DeepUll
DeepUll raises €13M Series B financing to progress early sepsis recognition platformFinancing led by new investors Innvierte and an undisclosed strategic investor with participation from existing...
DeepUll Appoints Richard Ivey to its Board of Directors
04 oct. 2021 07h00 HE
|
DeepUll
DeepUll Appoints Richard Ivey to its Board of Directors Diagnostics industry veteran with forty years’ experience to support DeepUll in its continued development of its early sepsis identification...
DeepUll Appoints Richard Ivey to its Board of Directors
04 oct. 2021 02h00 HE
|
DeepUll
DeepUll Appoints Richard Ivey to its Board of Directors Diagnostics industry veteran with forty years’ experience to support DeepUll in its continued development of its early sepsis identification...